Characterization of an allosteric citalopram-binding site at the serotonin transporter

Journal of Neurochemistry

Volumn 92, Issue 1, 2005, Pages 21-28

  Chen, Fenghua ^a   Larsen, Mads Breum ^a   Neubauer, Henrik Amtoft ^a   Sanchez, Connie ^b   Plenge, Per ^c   Wiborg, Ove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Bovine; Dissociation; Human; Mutagenesis; S citalopram

Indexed keywords

CITALOPRAM; DULOXETINE; FLUOXETINE; METHIONINE DERIVATIVE; OLIGOMER; PAROXETINE; SERINE DERIVATIVE; SEROTONIN; SEROTONIN TRANSPORTER; SERTRALINE; TYROSINE DERIVATIVE; VENLAFAXINE;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG BINDING SITE; HUMAN; MUTAGENESIS; MUTANT; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ALLOSTERIC SITE; ANIMALS; CATTLE; CELL LINE; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

BOVINAE;

EID: 13244283466     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02835.x     Document Type: Article

References (41)

1. Barker E. L. and Blakely R. D. (1995) Norepinephrine and Serotonin Transporters - Molecular Targets of Antidepressant Drugs, in Psychopharmacology: the Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., eds), pp. 321-333. Raven Press, New York.
2. Biessen E. A., Norder J. A., Horn A. S. and Robillard G. T. (1988) Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets. Biochem. Pharmacol. 37, 3959-3966.
3. Blakely R. D., Berson H. E., Fremeau R. T. Jr, Caron M. G., Peek M. M., Prince H. K. and Bradley C. C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70.
4. Bunin M. A. and Wightman R. M. (1998) Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 18, 4854-4860.
5. Chang A. S., Chang S. M., Starnes D. M., Schroeter S., Bauman A. L. and Blakely R. D. (1996) Cloning and expression of the mouse serotonin transporter. Brain Res. Mol Brain Res. 43, 185-192.
6. Chen J. G., Liu-Chen S. and Rudnick G. (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J. Biol. Chem. 273, 12 675-12 681.
7. Corey J. L., Quick M. W., Davidson N., Lester H. A. and Guastella J. (1994) A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization. Proc. Natl Acad. Sci. USA 91, 1188-1192.
8. Demchyshyn L. L., Pristupa Z. B., Sugamori K. S., Barker E. L., Blakely R. D., Wolfgang W. J., Forte M. A. and Niznik H. B. (1994) Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc. Natl Acad. Sci. USA 91, 5158-5162.
9. Foglia J. P., Pollock B. G., Kirshner M. A., Rosen J., Sweet R. and Mulsant B. (1997) Plasma levels of citalopram enantiomers and metabolites in elderly patients. Psychopharmacol. Bull. 33, 109-112.
10. Hoffman B. J., Mezey E. and Brownstein M. J. (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254, 579-580.
11. Humphreys C. J., Wall S. C. and Rudnick G. (1994) Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence. Biochemistry 33, 9118-9125.
12. Jess U., Betz H. and Schloss P. (1996) The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein. FEBS Lett. 394, 44-46.
13. Kilic F. and Rudnick G. (2000) Oligomerization of serotonin transporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 3106-3111.
14. Kocabas A. M., Rudnick G. and Kilic F. (2003) Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 1513-1520.
15. Kugelberg F. C., Apelqvist G., Carlsson B., Ahlner J. and Bengtsson F. (2001) In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Br. J. Pharmacol. 132, 1683-1690.
16. Lesch K. P., Wolozin B. L., Estler H. C., Murphy D. L. and Riederer P. (1993) Isolation of a cDNA encoding the human brain serotonin transporter. J. Neural Transm. Gen. Sect. 91, 67-72.
17. Meyerson L. R., Ieni J. R. and Wennogle L. P. (1987) Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets. J. Neurochem. 48, 560-565.
18. Miller G. M., De Yatin S. M., La G. R., Goulet M. and Madras B. K. (2001) Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res. Mol Brain Res. 87, 124-143.
19. Moret C. and Briley M. (1986) High- and low-affinity binding of [3H]imipramine in rat hypothalamus. J. Neurochem. 47, 1609-1613.
20. Mortensen O. V., Kristensen A. S., Rudnick G. and Wiborg O. (1999) Molecular cloning, expression and characterization of a bovine serotonin transporter. Brain Res. Mol Brain Res. 71, 120-126.
21. Mortensen O. V., Kristensen A. S. and Wiborg O. (2001) Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants. J. Neurochem. 79, 237-247.
22. O'Riordan C., Phillips O. M. and Williams D. C. (1990) Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine. J. Neurochem. 54, 1275-1280.
23. Owens M. J., Morgan W. N., Plott S. J. and Nemeroff C. B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp Ther 283, 1305-1322.
24. Ozaslan D., Wang S., Ahmed B. A., Kocabas A. M., McCastlain J. C., Bene A. and Kilic F. (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J. Biol. Chem. 278, 43 991-44 000.
25. Padbury J. F., Tseng Y. T., McGonnigal B., Penado K., Stephan M. and Rudnick G. (1997) Placental biogenic amine transporters: cloning and expression. Brain Res. Mol Brain Res. 45, 163-168.
26. Plenge P. and Mellerup E. T. (1985) Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes. Eur. J. Pharmacol. 119, 1-8.
27. Plenge P. and Mellerup E. T. (1997) An affinity-modulating site on neuronal monoamine transport proteins. Pharmacol. Toxicol. 80, 197-201.
28. Ramamoorthy S., Bauman A. L., Moore K. R., Han H., Yang-Feng T., Chang A. S., Ganapathy V. and Blakely R. D. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter, molecular cloning, expression, and chromosomal localization. Proc. Natl Acad. Sci. USA 90, 2542-2546.
29. Ramamoorthy S. and Blakely R. D. (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285, 763-766.
30. Ranganathan R., Sawin E. R., Trent C. and Horvitz H. R. (2001) Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine. J. Neurosci. 21, 5871-5884.
31. Sanchez C., Bergqvist P. B., Brennum L. T., Gupta S., Hogg S., Larsen A. and Wiborg O. (2003) Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) 167, 353-362.
32. Sandhu S. K., Ross L. S. and Gill S. S. (2002) A cocaine insensitive chimeric insect serotonin transporter reveals domains critical for cocaine interaction. Eur. J. Biochem. 269, 3934-3944.
33. Schloss P. and Betz H. (1995) Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1. Biochemistry 34, 12 590-12 595.
34. Schmid J. A., Scholze P., Kudlacek O., Freissmuth M., Singer E. A. and Sitte H. H. (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 3805-3810.
35. Segonzac A., Raisman R., Tateishi T., Schoemaker H., Hicks P. E. and Langer S. Z. (1985) Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction. J. Neurochem. 44, 349-356.
36. Sette M., Briley M. S. and Langer S. Z. (1983) Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers. J. Neurochem. 40, 622-628.
37. Sur C., Betz H. and Schloss P. (1998) Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1. J. Neurochem. 70, 2545-2553.
38. Tate C. G. and Blakely R. D. (1994) The effect of N-linked glycosylation on activity of the Na (+)- and Cl (-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J. Biol. Chem. 269, 26 303-26 310.
39. Tatsumi M., Groshan K., Blakely R. D. and Richelson E. (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 340, 249-258.
40. Wennogle L. P. and Meyerson L. R. (1982) Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites. Eur. J. Pharmacol. 86, 303-307.
41. Wennogle L. P. and Meyerson L. R. (1985) Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes. Life Sci. 36, 1541-1550.